Dermatomyositis and systemic lupus erythematosus overlap syndrome

Authors

Abstract

The case report of an 58 years female is diagnosed with systemic lupus erythematosus She went to the Internal Medicine service with muscular weakness, myalgia, arthralgia, and skin rashes. Physical examination revealed signs of dermatomyositis, such as heliotrope rash, Gottron's papules, oral ulcers, and cutaneous mycoses. Additional tests revealed elevated antinuclear antibodies and creatine kinase levels. After a diagnosis of overlap syndrome due to dermatomyositis and systemic lupus erythematosus, treatment was initiated, with favorable clinical outcome. The importance of prolonged follow-up and immunosuppressive therapies that allow control of the disease was evident.

Downloads

Download data is not yet available.

Author Biographies

Eliecer González Valdéz, Hospital General Provincial Camilo Cienfuegos. Universidad de Ciencias Médicas Sancti Spiritus

Especialista de Segundo Grado en Medicina Interna, Máster en Ciencias Pedagógicas, Profesor Auxiliar. Hospital General Provincial “Camilo Cienfuegos” de Sancti Spíritus. Cuba

Miguel Angel Amaró Garrido, Policlínico Universitario “Juana Naranjo León” de Sancti Spíritus

Especialista de Segundo Grado en Imagenología, Especialista de Primer Grado en Medicina General Integral, Máster en Ciencias Pedagógicas, Profesor Auxiliar, Investigador Agregado, Policlínico Universitario “Juana Naranjo León” de Sancti Spíritus. Cuba

Tatiana Hernández González, Hospital General Provincial “Camilo Cienfuegos” de Sancti Spíritus.

Especialista de Segundo Grado en Cirugía Plástica y Caumatología, Máster en Ciencias Pedagógicas y Medicina Bioenergética y Natural, Profesora Auxiliar, Investigador Agregado, Hospital General Provincial “Camilo Cienfuegos” de Sancti Spíritus.

References

1.Greenberg SA, Amato AA. Miopatías inflamatorias. En: Loscalzo J, Fauci A, Kasper D, Hauser S, Longo D, Jameson JL, editores. Harrison: Principios de Medicina Interna. 21. ed. McGraw Hill. 2023[citado 18/07/2024]:6-15. Disponible en: https://accessmedicina.mhmedical.com/book.aspx?bookID=3118

2.Greenberg SA. Miopatías inflamatorias. En: Goldman L, Schafer AI, editores. Goldman-Cecil: Tratado de Medicina Interna. 26. ed. España: Elsevier; 2021[citado 18/07/2024]:1747-52. Disponible en: https://www.edicionesjournal.com//Papel/9788491137658/Goldman-Cecil++Tratado+de+Medicina+Interna+Ed+26

3.Williams P, McKinney B. Refractory dermatomyositis–systemic lupus erythematosus overlap syndrome and response to tofacitinib. Bayl Univ Med Cent Proc. 2020 [citado 09/08/2024]; 34(1):116-7. Disponible en: https://doi.org/10.1080/08998280.2020.1821589

4.Sapkota B, Al Khalili Y. Enfermedad mixta del tejido conectivo. En: Stat Pearls. Treasure Island (FL): Stat Pearls Publishing. 2024 [citado 27/07/2024]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK542198/

5. Chiang HL, Tung CH, Huang KY, Hsu BB, Wu CH, Hsu CW, et al. Association between clinical phenotypes of dermatomyositis and polymyositis with myositis-specific antibodies and overlap systemic autoimmune diseases. Medicine. 2021 [citado 02/10/2024];100(37): e27230. Disponible en: https://doi.org/10.1097/md.0000000000027230

6.Dey B, Rapahel V, Khonglah Y, Jamil M. Systemic lupus erythematosus-myositis overlap syndrome with lupus nephritis. J Fam Med Prim Care. 2020 [citado 09/08/2024];9(4):2104. Disponible en: https://doi.org/10.4103/jfmpc.jfmpc_186_20

7. Jain S, Sharma A. Lupus versus dermatomyositis: the hands say it all. Rheumatology. 2020 [citado 18/09/2024];59(9):2647. Disponible en: https://doi.org/10.1093/rheumatology/kez679

8.Varma A, Kumar S, Salve R, Kher A, Vagha J, Damke S. Rare presentation of systemic lupus erythematosus with juvenile dermatomyositis. Indian J Forensic Med Amp Toxicol. 2020 [citado 09/10/2024]. Disponible en: https://doi.org/10.37506/ijfmt.v14i4.12576

9. A Rare Presentation of Systemic Lupus Erythematosus with Juvenile Dermatomyositis. Indian Journal of Forensic Medicine & Toxicology. 2020[cited 21/07/2024];14(4):6237-40. Disponible en: https://medicopublication.com/index.php/ijfmt/article/view/12576

10.Pandya R, Lim D, Kleitsch J, Werth VP. Overlap of dermatomyositis and cutaneous lupus erythematosus: a case series. JAAD Case Rep. 2023 [citado 09/10/2024]. Disponible en: https://doi.org/10.1016/j.jdcr.2023.10.00z

11. Iwakura M, Murai M, Sasai T, Matsuoka M. Overlap syndrome involving anti-OJ antibody-positive polymyositis, systemic lupus erythematosus and Sjögren's syndrome: A case report and literature review. Modern rheumatology case reports. 2023[citado 25/07/2024];7(2):399–03. Disponible en: https://doi.org/10.1093/mrcr/rxac087

12. Chong Benjamin F, Werth V. Cutaneous lupus erythematosus and dermatomyositis: Utilizing assessment tools for treatment efficacy. Journal of Investigative Dermatology .2022[citado 25/07/2024];142(3): 936-43. Disponible en:https://doi.org/10.1016/j.jid.2021.09.036

13.Maddukuri S, Patel J, Werth VP. Photosensitivity in lupus erythematosus and dermatomyositis. Curr Dermatol Rep. 2020 [citado 06/10/2024];9(2):93-9. Disponible en: https://doi.org/10.1007/s13671-020-00300-7

Downloads

Published

2025-08-06

How to Cite

1.
González Valdéz E, Amaró Garrido MA, Hernández González T. Dermatomyositis and systemic lupus erythematosus overlap syndrome. MEDISAN [Internet]. 2025 Aug. 6 [cited 2025 Sep. 3];29:e5093. Available from: https://medisan.sld.cu/index.php/san/article/view/5093

Issue

Vol. 29 (2025): publicación continua

Section

Case Reports

License

Copyright (c) 2025 MEDISAN

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.